| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | — | — |
| R&D Expense | $65.0M | — | +59.7% |
| SG&A Expense | $11.7M | — | -9.7% |
| Operating Income | -$73.6M | — | -37.3% |
| Income Tax | $0 | — | — |
| Net Income | -$68.8M | — | -43.3% |
| EPS (Basic) | -$1.01 | — | -17.4% |
| EPS (Diluted) | -$1.01 | — | -17.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.5M | +20.3% | -45.7% |
| Short-term Investments | $318.4M | -7.0% | +69.4% |
| Current Assets | $405.4M | -1.9% | +21.9% |
| Total Assets | $512.9M | -9.5% | -0.5% |
| Current Liabilities | $43.4M | -1.3% | +61.4% |
| Total Liabilities | $61.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$68.1M | — | -42.6% |
| Investing Cash Flow | $68.9M | — | +115.6% |
| Financing Cash Flow | $11.5M | — | — |
| +32.7% |
| Stockholders' Equity | $451.8M | -10.6% | -3.8% |